Keros Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Keros Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q3 2024.
  • Keros Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $19.8M, a 26.5% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $19.8M +$4.15M +26.5% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $14.6M -$1.36M -8.5% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $15M -$1.37M -8.37% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $15.3M -$214K -1.38% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $15.7M +$15.2M +3405% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $16M +$15.4M +2333% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $16.4M +$15.5M +1794% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $15.5M +$14.5M +1357% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $447K -$818K -64.7% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $658K -$18K -2.66% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $864K +$85K +10.9% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $1.07M +$189K +21.5% Dec 31, 2021 10-K 2023-03-03
Q3 2021 $1.27M +$289K +29.6% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $676K -$349K -34% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $779K -$337K -30.2% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $878K -$327K -27.1% Dec 31, 2020 10-K 2022-03-09
Q3 2020 $976K Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $1.03M Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $1.12M Mar 31, 2020 10-Q 2020-05-22
Q4 2019 $1.21M Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.